Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

Presenter: Upendra Kaul

October 28, 2025

Presentation TCT 2025

Fire trial: The impact of Supraflex Cruz performance on 3-year data

Presenter: Simone Biscaglia

October 28, 2025

Presentation TCT 2025

Cruz Senior trial (Supraflex Cruz in all-comer elderly patients)

Presenter: David M. Leistner

October 28, 2025

Presentation TCT 2025

Tuxedo-II trial : Supraflex Cruz vs Xience Family stents comparison

Presenter: Upendra Kaul

October 28, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

Presentation JIM 2020

Supraflex Cruz in the challenging scenario of older MI patients

Presenter: Gianluca Campo

February 13, 2020

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

Advertisement

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

Fire trial: The impact of Supraflex Cruz performance on 3-year data

Cruz Senior trial (Supraflex Cruz in all-comer elderly patients)

Tuxedo-II trial : Supraflex Cruz vs Xience Family stents comparison

What’s Going to Be Hot at TCT 2025

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Supraflex Cruz in the challenging scenario of older MI patients

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content